bloodadvances.orgBlood Advances

') Skip to Main Content Advertisement Close Blood Blood Advances Hematology ASH-SAP ASH Clinical News The Hematologist International Blood Chinese Edition Blood Japanese Edition Blood Italian Edition Blood Latin America Edition Blood Spanish Edition ASH ASH Home Research Education Advocacy Meetings Publications ASH Store Cart User Tools Cart Sign In Search search input Search input auto suggest search filter All Content All Journals Blood Advances Search Toggle Menu Menu Issues Current Issue All Issues Latest Articles Guidelines Collections Collections Special Collections Multimedia Alerts Author Center Submit Author Guide Style Guide About About Blood Advances Editorial Board and Staff Copyright Alerts Current Issue Volume 4 , Issue 19 , October 13, 2020 View This Issue Latest Articles Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML Reduced prevalence of SARS-CoV-2 infection in ABO blood group O Next-generation sequencing of 35 RHD variants in 16 253 serologically D − pregnant women in the Finnish population The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement Midostaurin in patients with acute myeloid leukemia and FLT3 -TKD mutations: a subanalysis from the RATIFY trial Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews Advertisement Message from ASH President on Diversity, Equity, and Inclusion Authors and Reviewers: New COVID-19 Announcement Featured Content Naive T-cell depletion in stem cell transplantation Engineering of the hematopoietic graft is an attractive approach to improving outcomes for patients undergoing hematopoietic cell transplantation. In this issue’s Blood Advances Talk, Marie Bleakley describes her group’s efforts in depletion of naïve T cells to reduce graft-versus-host disease and maintain graft-versus-tumor reactions. We hope you find this talk useful and informative. Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 The use of convalescent plasma for the treatment of patients with COVID-19 continues to of great interest and recent clinical application. In an Exceptional Case Report, Luetkens and colleagues describe a patient with multiple myeloma and hypogammaglobulinemia who developed severe COVID-19 and was successfully treated with convalescent plasms, highlighting the potential effectiveness of this therapeutic. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews In hospitalized medical patients, the risk of venous thromboembolism (VTE) must be counter balanced by the risk of bleeding when considering anticoagulation strategies. In a Systematic Review, Darzi and colleagues evaluate risk assessment models which informed the formation of the American Society of Hematology’s Clinical Guidelines addressing VTE. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients Blastic plasmacytoid dendritic cell neoplasms (BPDCNs) are rare but carry a dismal prognosis. In an international survey of 398 adult patients, Laribi and colleagues evaluated various treatment strategies with important clinical conclusions that could help standardize therapy and lead to future improvements in outcomes of this devastating disease. Human ferroportin mediates proton-coupled active transport of iron Ferroportin is known as perhaps the sole iron exporter in humans. However, the molecular mechanisms involved are incompletely understood. Li and colleagues explored targeted mutagenesis of ferroportin to gain further insight into the molecular mechanisms of action of this important iron transporter. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE) Treatment of children with catheter-related thrombosis has not been specifically addressed in a comprehensive way. Thom and colleagues, on behalf of the EINSTEIN-Jr. CVC-VTE investigators, evaluated 500 children to provide important clinical observations on the treatment of this patient population. Advertisement Affiliations -- Current Issue Latest Articles Collections Community Conversations Blood Advance Talks All Issues Newsroom Copyright Permissions Submit to Blood Advances Alerts Contact Us Order Reprints Advertising in Blood Advances Authors Twitter American Society of Hematology 2021 L Street NW, Suite 900 Washington, DC 20036 TEL +1 202-776-0544 FAX +1 202-776-0545 ASH Publications Blood Blood Advances Hematology, ASH Education Program ASH Clinical News ASH-SAP The Hematologist American Society of Hematology ASH Home Research Education Advocacy Meetings Publications ASH Store Copyright ©2020 by American Society of Hematology Privacy Policy Cookie Policy Terms of Use Contact Us Close Modal This Feature Is Available To Subscribers Only Sign In or Create an Account Close Modal Close Modal Advertisement X...